Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 90466Y202 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
Vivo Opportunity Fund Holdings, L.P.
13G/A
Amendment 4
|
10.0% |
8/14/2026
Event 6/30/2026
|
|
| Vivo Opportunity Fund Holdings, L.P. | 10.0% | ||
| Vivo Opportunity, LLC | 10.0% | ||
|
Nantahala Capital Management, LLC
13G/A
Amendment 10
|
10.0% |
8/14/2026
Event 6/30/2026
|
|
| Nantahala Capital Management, LLC | 10.0% | ||
| Wilmot B. Harkey | 10.0% | ||
| Daniel Mack | 10.0% | ||
| BlackRock, Inc. 13G | 5.3% |
7/30/2026
Event 6/30/2026
|
|
|
Integrated Core Strategies (US) LLC
13G/A
Amendment 1
|
1.0% |
7/8/2026
Event 6/30/2026
|
|
| Integrated Core Strategies (US) LLC | 0.8% | ||
| Millennium Management LLC | 1.0% | ||
| Millennium Group Management LLC | 1.0% | ||
| Israel A. Englander | 1.0% | ||
|
RA Capital Management, L.P.
13G/A
Amendment 7
|
9.9% |
5/15/2026
Event 3/31/2026
|
|
| RA Capital Management, L.P. | 9.9% | ||
| Peter Kolchinsky | 9.9% | ||
| Rajeev Shah | 9.9% | ||
| RA Capital Healthcare Fund, L.P. | 9.9% | ||
|
RA Capital Management, L.P.
13G/A
Amendment 6
|
9.9% |
2/17/2026
Event 12/31/2025
|
|
| RA Capital Management, L.P. | 9.9% | ||
| Peter Kolchinsky | 9.9% | ||
| Rajeev Shah | 9.9% | ||
| RA Capital Healthcare Fund, L.P. | 9.9% | ||
|
Nantahala Capital Management, LLC
13G/A
Amendment 9
|
10.0% |
2/13/2026
Event 12/31/2025
|
|
| Nantahala Capital Management, LLC | 10.0% | ||
| Wilmot B. Harkey | 10.0% | ||
| Daniel Mack | 10.0% | ||
|
Octagon Capital Advisors LP
13G/A
Amendment 3
|
4.7% |
2/10/2026
Event 12/31/2025
|
|
| Octagon Capital Advisors LP | 4.7% | ||
| Octagon Investments Master Fund LP | 3.0% | ||
| Octagon Biotech Opportunities Fund I LP | 1.7% | ||
| Ting Jia | 4.7% | ||
|
Integrated Core Strategies (US) LLC
13G
|
5.5% |
1/23/2026
Event 1/16/2026
|
|
| Integrated Core Strategies (US) LLC | 5.5% | ||
| Millennium Management LLC | 5.5% | ||
| Millennium Group Management LLC | 5.5% | ||
| Israel A. Englander | 5.5% | ||
|
Great Point Partners, LLC
13G/A
Amendment 4
|
4.5% |
11/14/2025
Event 9/30/2025
|
|
| Great Point Partners, LLC | 4.5% | ||
| Dr. Jeffrey R. Jay, M.D. | 4.5% | ||
| Ms. Lillian Nordahl | 4.5% | ||
|
RA Capital Management, L.P.
13G/A
Amendment 5
|
9.9% |
11/14/2025
Event 9/30/2025
|
|
| RA Capital Management, L.P. | 9.9% | ||
| Peter Kolchinsky | 9.9% | ||
| Rajeev Shah | 9.9% | ||
| RA Capital Healthcare Fund, L.P. | 9.9% | ||
|
Octagon Capital Advisors LP
13G/A
Amendment 2
|
5.7% |
11/14/2025
Event 9/30/2025
|
|
| Octagon Capital Advisors LP | 5.7% | ||
| Octagon Investments Master Fund LP | 3.7% | ||
| Octagon Private Opportunities Fund II LP | 2.0% | ||
| Ting Jia | 5.7% | ||
|
Vivo Opportunity Fund Holdings, L.P.
13G/A
Amendment 3
|
10.0% |
11/14/2025
Event 9/30/2025
|
|
| Vivo Opportunity Fund Holdings, L.P. | 10.0% | ||
| Vivo Opportunity, LLC | 10.0% | ||
|
Great Point Partners, LLC
13G/A
Amendment 3
|
6.2% |
8/14/2025
Event 6/30/2025
|
|
| Great Point Partners, LLC | 6.2% | ||
| Dr. Jeffrey R. Jay, M.D. | 6.2% | ||
| Ms. Lillian Nordahl | 6.2% | ||
|
Biotechnology Value Fund L P
13G/A
Amendment 2
|
10.0% |
8/14/2025
Event 6/30/2025
|
|
| Biotechnology Value Fund L P | 5.7% | ||
| BVF I GP LLC | 5.7% | ||
| Biotechnology Value Fund II LP | 4.4% | ||
| BVF II GP LLC | 4.4% | ||
| Biotechnology Value Trading Fund OS LP | 0.3% | ||
| BVF Partners OS Ltd. | 0.3% | ||
| BVF GP Holdings LLC | 9.7% | ||
| BVF Partners L P/IL | 10.0% | ||
| BVF Inc/IL | 10.0% | ||
| Lampert Mark N | 10.0% | ||
|
Octagon Capital Advisors LP
13G/A
Amendment 1
|
7.8% |
8/12/2025
Event 6/30/2025
|
|
| Octagon Capital Advisors LP | 7.8% | ||
| Octagon Investments Master Fund LP | 5.1% | ||
| Octagon Private Opportunities Fund II LP | 2.7% | ||
| Ting Jia | 7.8% |